During the 12th Annual Scientific Sessions (January 29 to February 1, 2009) of the Society for Cardiovascular Magnetic Resonance (SCMR), the world's major international society for cardiovascular imaging, the role of magnetic resonance imaging to assess the effect of therapy in patients with acute myocardial infarction will be demonstrated in a series of papers.

Manhattan Research, a global healthcare and pharmaceutical market research company, has announced the launch of Taking the Pulse® Asia, its latest physician market research and advisory service. The service is part of Manhattan Research's overall insight into global digital trends and focuses on physicians across Japan, China, South Korea, Taiwan, and Australia.

Medicines impact the lives of millions of people and strengthen their well-being, but there are risks involved in their use. Scientists agree that risk assessment during drug development should be carried out rigorously, but identifying safety concerns during clinical trials is complex. Pharmacovigilance is a field of science dedicated to the understanding and prevention of the adverse effects of medicines.

A study by healthcare market research firm Manhattan Research found that only 9% of U.S. physicians oppose commercial support for continuing medical education (CME) funding. The results of this study are relevant to the ongoing discussion in the medical community about the role of commercial funding of CME.

Manhattan Research, a global healthcare and pharmaceutical market research company, today announced the release of Taking the Pulse® Europe v8.0, its European physician study and strategic advisory service. It offers in-depth market data and analysis of how physicians across Western Europe integrate the Internet and technology into their practises. Taking the Pulse® Europe also looks at key trends in pharma company/sales rep interactions and electronic detailing.

Manhattan Research, a global pharmaceutical and healthcare market research company, releases its latest physician analysis titled "Physician Online Communities: Physician Social Networking and the New Online Opinion Leaders" as part of the Taking the Pulse® physician market research and strategic advisory service.

Scientists from Helmholtz Zentrum München have developed a breakthrough methodology for understanding metabolism related variations from experimental genomics data. Using proposed bioinformatics strategy they were able to demonstrate that in most cases identified disease-specific metabolism variations are not independent, e.g. deregulated genes from different pathways are linked to each other via one or two step of consecutive metabolic reactions.